project id: TCGA-CESC; case submitter id: TCGA-EK-A2PM; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.4; age at index: 81; days to birth: -29747; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1927; age at diagnosis: 29747; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 18.0; figo stage: Stage IIB; icd 10 code: C53.9; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1199; initial weight: 100.0; oct embedded: false; preservation method: Unknown; sample id: 2e7f29fb-97de-4ee0-bca7-6a51c4c3e5cf; sample submitter id: TCGA-EK-A2PM-01A; portion id: 27c5d8d1-b991-4b21-a2fc-d9fba47e559b; portion submitter id: TCGA-EK-A2PM-01A-11; slide id: f38f22d1-cddb-4bfe-8bb6-2b8654ebf21a; slide submitter id: TCGA-EK-A2PM-01A-01-TS1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 15.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 80.0; percent tumor nuclei: 96.0; section location: TOP;